-
Study shows why second dose of COVID-19 vaccine shouldn’t be skipped
firstwordpharma
July 20, 2021
The second dose of a COVID-19 vaccine induces a powerful boost to a part of the immune system that provides broad antiviral protection, according to a study led by investigators at the Stanford University School of Medicine.
-
Novel Autoantibody Adds Fuel to COVID-19 “Firestorm” of Inflammation, Blood Clots
firstwordpharma
July 20, 2021
Researchers at Michigan Medicine have discovered yet another functional autoantibody in COVID-19 patients that contributes to the disease's development and the "firestorm" of blood clots and inflammation it induces.
-
NRx Pharmaceuticals Presents Evidence ZYESAMI™ (aviptadil) Helps Prevent "Cytokine Storm" in Patients with COVID-19
prnewswire
July 20, 2021
The presentation identifies a statistically significant effect of ZYESAMI™ (aviptadil) in preventing the sharp rise in cytokines, commonly associated with mortality in patients with COVID-19.
-
RedHill Biopharma Announces Last Patient Out for Phase 2/3 COVID-19 Study of Oral Opaganib
prnewswire
July 20, 2021
RedHill Biopharma Ltd. today announced that all treatment and follow-up has now been completed in the 475-patient global Phase 2/3 study with opaganib (ABC294640)[1] in patients hospitalized with severe COVID-19 pneumonia (NCT04467840).
-
Cityzenith and SafelyThrive Digital Twin tech partnership delivers major solution to 'COVID Delta' variant
prnewswire
July 20, 2021
As the world reels from the threat of COVID-19's new and highly contagious Delta variant, two US companies say their new alliance offers real hope of safe co-existence with the virus and potential future infectious diseases.
-
New Study Reveals 63% of Healthcare Providers Plan Time Off from Practice, While Demand Increases for Some Specialties
prnewswire
July 20, 2021
Perhaps no other industry in the United States was as uniquely impacted by the COVID-19 crisis as the healthcare system. The effects varied vastly across the industry, causing some physicians work overload and others scarcity and job loss.
-
Mirimus, Inc. Announces Publication of Research in The Lancet-Affiliated Journal EClinicalMedicine Discussing Pooled, Saliva-Based COVID-19 Testing as Efficient, Affordable Surveillance Approach for K
prnewswire
July 20, 2021
Mirimus, Inc., a leader in conducting high-volume, high-quality PCR testing, today announced the publication of a peer-reviewed paper by EClinicalMedicine, an open access medical journal published by The Lancet.
-
AI, big data will continue to disrupt pharma sector, say healthcare industry professionals in GlobalData survey
expresspharma
July 19, 2021
The COVID-19 pandemic has given businesses an unprecedented opportunity to implement technology-fueled changes to the way they operate.
-
India tops in number of unvaccinated, under-vaccinated kids worldwide: UNICEF
expresspharma
July 19, 2021
India has the highest number of under-vaccinated or unvaccinated children worldwide at 3.5 million, an increase of 1.4 million from 2019, amid the COVID-19 pandemic outbreak, the UNICEF said.
-
CDC Advisers to Discuss Third COVID-19 Vaccine Dose for Immunocompromised
drugs
July 19, 2021
Giving a third dose of COVID-19 vaccines to immunocompromised adults will be up for discussion during a U.S. Centers for Disease Control and Prevention advisory panel meeting next week.